'Transformative' pancreatic cancer drug doubles survival time
People with advanced pancreatic cancer taking an experimental daily pill lived nearly twice as long as those receiving chemotherapy infusions
New Scientist — 1 June 2026
Text:
4
0
0
People with advanced pancreatic cancer taking an experimental daily pill lived nearly twice as long as those receiving chemotherapy infusions
This report comes from New Scientist. The story centres on 'Transformative' pancreatic cancer drug doubles survival time. Full coverage and background context is available at the original source. Readers seeking more detail on this developing topic are encouraged to follow updates from New Scientist and related outlets covering this beat.
Sources
🔬 Science
NASA Awards Contract for Johnson Space Center Infrastructure
🔬 Science
'Astonishing': James Webb telescope spots the most chemically primitive galaxy in the ancient universe
🔬 Science
Astronomers gaze into the 'Crystal Ball Nebula' and see a vision of our dying sun — Space photo of the week
🔬 Science
Bacteria uncover distinct strategy to import rare sugar polymers, crystal structures show
🔬 Science
Repairing DNA damage: Scientists discover a surprising new benefit of melatonin
🔬 Science
Putin's quest to avoid the grim reaper: What’s behind the $26 Billion longevity programme?
